Organizational Change & Capability Advisory

Delphi is a psychedelic healthcare consultancy focused on responsible integration into mainstream care. Led by Lia Mix and a cross-sector team, Delphi supports healthcare providers, investors, government agencies, and psychedelic organisations with strategy, education, and implementation guidance across regulation, delivery, and reimbursement. A major Delphi initiative is IHPI (Ibogaine Healthcare Policy Institute), a neutral, evidence-based, implementation-focused institute that develops coverage playbooks, health-economics models, and delivery blueprints for safe ibogaine adoption. Delphi also leads HOPE (Health Outcomes and Psychedelic Economics), a collaborative effort to generate independent economic evidence that can inform payer policy and broader healthcare access decisions.

US psychedelic drug-development consultancy providing clinical trial roadmaps, regulatory planning, and operational integration frameworks for emerging neuropsychiatry programs.

UK-based psychedelic-focused consultancy offering strategic and business development services, education curriculum design, and partner collaborations for organizations in the sector.

Psychedelic integration and advisory practice offering preparation/integration support and explicit psychedelic business consulting and coaching for practitioners and service builders.

Psychedelic Alpha (Pα) is an independent, data-driven psychedelic media, research and advisory platform, founded in 2020 by Josh Hardman and based in London. It publishes the widely read weekly Psychedelic Bulletin newsletter alongside closely followed trackers of psychedelic drug development and of psychedelic law and policy, and provides advisory and consultancy services to investors, philanthropists, government agencies, startups and established firms. It is known for cutting through hype to surface what matters in the development, regulation and commercialisation of psychedelic medicines.

US-based consultancy supporting hospitals and clinics with psychedelic and ketamine service implementation, including strategic planning, staffing, protocol setup, and quality systems.

Purpose-led healthcare consultancy focused on integrating psychedelic-assisted therapy into health systems, with explicit services across strategic planning, implementation, reimbursement, and go-to-market execution.

Miami-based boutique consulting firm supporting cannabis and psychedelic organizations with product strategy, operational optimization, and capability development.